News

News 19th February 2019 – Biotherapeutic Formulation Development Spray Drying Biotherapeutics Dry powder formulations of Biotherapeutics eliminate the need for expensive cold chain storage and facilitate supply chain management. Lyophilisation is traditionally used for the drying process, but in recent years the semi-continuous, robust and scalable qualities of spray drying have made it the drying … Read more

News 5th February 2019 – Non-GMP Pilot Plant Extended Capabilities Upperton Pharma Solutions now has a fully commissioned 60 square metre non-GMP pilot plant, mirroring our GMP manufacturing facility. The pilot plant is equipped for three scales of spray drying: ProCept 4M8-Trix for batch sizes of up to 300g Upperton Intermediate Spray Dryer for batch sizes … Read more

News 22nd January 2019 – Successful completion of EU Horizon 2020 Grant MACIVIVA In 2014, Upperton Pharma Solutions was awarded a prestigious Horizon 2020 MACIVIVA grant as part of a European consortium led by Mymetics, a pioneering company at the forefront of the development of virosome-based vaccines. The MACIVIVA goal was to develop dry powder, thermostable, … Read more